Lacosamide Arrow

Lacosamide, the active ingredient in Lacosamide Arrow, is a anti‑epileptic drug presented as a intravenous solution for intravenous use. It treats partial‑onset seizures and is used in status epilepticus. GNH USA supplies Lacosamide Arrow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Lacosamide is an anti‑epileptic agent used in the management of seizure disorders. - Partial‑onset seizures: added to existing therapy to reduce seizure frequency. - Status epilepticus: administered intravenously to terminate ongoing seizures. - Focal epilepsy: used as adjunctive therapy to improve seizure control.

Adverse reactions may occur with lacosamide therapy.

Common Side Effects: - Dizziness - Nausea - Headache - Fatigue

Serious or Rare Side Effects: - Cardiac arrhythmia (including PR interval prolongation) - Severe skin reactions such as Stevens‑Johnson syndrome - Respiratory depression

Lacosamide should be used with attention to patient‑specific factors and proper handling. - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: use caution and consider dose adjustment. - Concomitant antiepileptic drugs: assess for altered efficacy or toxicity. - Pregnancy: risk unknown; weigh benefits against potential risks. - Elderly patients: monitor for dizziness and falls. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lacosamide may interact with other medicines, requiring vigilance.

Major Interactions (Avoid): - Carbamazepine, phenytoin, phenobarbital: strong enzyme inducers that may reduce lacosamide levels.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may increase lacosamide exposure. - Valproate: may affect plasma concentrations. - Beta‑blockers: monitor for additive cardiovascular effects.